Updated:
MedStartr
MedStartr was established as a crowdfunding platform tailored to healthcare and life sciences, leveraging the JOBS Act framework to allow non-accredited...
MedStartr
MedStartr was established as a crowdfunding platform tailored to healthcare and life sciences, leveraging the JOBS Act framework to allow non-accredited investors to participate in early-stage health-tech deals. Its founders built the platform to address the capital gap in medical innovation, where regulatory hurdles often deter traditional venture investors. The firm's strategy centers on equity crowdfunding and rewards-based campaigns for companies in digital health, medical devices, diagnostics, and healthcare services. It sources deal flow through its online community, industry partnerships, and healthcare-focused accelerators. Geographic focus is primarily North America, with some campaigns extending to European and Asian health-tech startups. MedStartr's team size and operational footprint remain undisclosed, and no public filings detail its total deployment or AUM. The platform operates as an intermediary rather than a principal investor, earning fees from successful campaigns. No recent operational events are on record. A structural differentiator is MedStartr's niche focus on healthcare regulation — it provides campaign guidance on FDA, HIPAA, and other compliance issues, a service most generalist crowdfunding platforms lack. This positions it as a vertical-specific capital formation tool rather than a diversified crowdfunding site.
General information
Firm type
other
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
How does MedStartr source its deal flow?
MedStartr sources deals through its online community, healthcare industry partnerships, and startup accelerators focused on health-tech. The platform also accepts applications directly from entrepreneurs. Because it operates as a crowdfunding intermediary, deal flow is driven by self-selection and network effects rather than proprietary sourcing (per public record).
Is MedStartr a single-family office or an investment platform?
MedStartr is not a family office; it is a crowdfunding platform and community for health-tech startups. It facilitates equity and rewards-based fundraising campaigns, acting as an intermediary between startups and investors, including both accredited and non-accredited individuals under Regulation Crowdfunding. It does not deploy its own balance sheet capital.
What investment stages does MedStartr target?
MedStartr typically targets early-stage companies, from pre-seed through Series A, in the digital health, MedTech, and healthcare services sectors. Its campaigns often support companies that have not yet attracted institutional venture capital, making it a bridge for initial capital formation (per public record).
Does MedStartr have any relationship with traditional venture capital firms?
Public records do not indicate formal equity ties to named venture firms. MedStartr operates as a standalone platform that may host campaigns from startups that later raise from VCs, but it is not structured as a fund or a conduit for institutional capital. Its model is transactional and community-based.
Where does MedStartr's revenue come from?
MedStartr earns fees from successful crowdfunding campaigns, typically a percentage of funds raised, plus any additional charges for platform services such as compliance guidance or marketing. It does not charge management fees or carried interest, as it is not a fund manager.
What sectors does MedStartr specifically target, and are there any it avoids?
MedStartr explicitly targets digital health, medical devices, diagnostics, healthcare services, and life science tools. It avoids sectors unrelated to healthcare, such as consumer goods, real estate, or general technology, reflecting its niche focus. The platform's compliance-guided model also makes it unsuitable for high-risk therapeutic areas without clear regulatory pathways.
How does MedStartr handle compliance for regulated health-tech campaigns?
MedStartr provides guidance on regulatory requirements such as FDA premarket submissions, HIPAA privacy rules, and SEC crowdfunding regulations. Campaigns must meet basic due diligence standards, but the platform does not guarantee regulatory approval. It advises entrepreneurs to engage legal and regulatory counsel (per public record).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: